A Study of MD-120 in Patients With Depression
A Study of MD-120 in Patients With Depression
The purpose of this study is to verify the efficacy and evaluate the safety of 8-week
 once-daily oral administration of MD-120 in Japanese patients with depression.
Inclusion Criteria:

 -  Patient with diagnosis of Major Depressive Disorder (MDD) based on the criteria in the
 Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5).

 -  HAM-D 17 total score of ≥20.

 Exclusion Criteria:

 -  Patient who meets DSM-5 criteria of the following disorders for current or past
 history.

 Schizophrenia spectrum and other psychotic disorders Bipolar and related disorders
 Substance use disorders (exclusive of tobacco and caffeine)

 -  Patient who had suicidal behavior in Columbia-Suicide Severity Rating Scale (C-SSRS)
 within 1 year before start of screening phase.